![Chihiro Yabe](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chihiro Yabe
Corporate Officer/Principal chez Kyoto Prefectural University of Medicine
Profil
Chihiro Yabe is the founder of Calliditas Therapeutics Suisse SA, which was founded in 2006.
Currently, Dr. Yabe holds the position of Professor at Kyoto Prefectural University of Medicine.
Postes actifs de Chihiro Yabe
Sociétés | Poste | Début |
---|---|---|
Kyoto Prefectural University of Medicine | Corporate Officer/Principal | - |
Anciens postes connus de Chihiro Yabe
Sociétés | Poste | Fin |
---|---|---|
Calliditas Therapeutics Suisse SA
![]() Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Calliditas Therapeutics Suisse SA
![]() Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Health Technology |